This is a consensus statement from an international group, mostly of clinical endocrinologists.
MEN1 and MEN2 are hereditary cancer syndromes. The commonest tumors secrete PTH …

Objective To study the clinical, pathologic, and genetic features of thymic carcinoids in the
setting of multiple endocrine neoplasia type 1 (MEN1) and to study means for detection and …

Pheochromocytoma and paraganglioma (PPGL) can be divided into at least four molecular
subgroups. Whether such categorizations are independent factors for prognosis or metastatic …

Multiple endocrine neoplasia type 1 (MEN-1) is a predisposition to hyperplasia of the
parathyroid glands, and to hyperplasia or tumours of the anterior pituitary and the endocrine …

Background Adrenocortical carcinoma is a rare cancer that has a poor response to cytotoxic
treatment. Methods We randomly assigned 304 patients with advanced adrenocortical …

Purpose: A retrospective analysis of the toxicity and efficacy of temozolomide in advanced
neuroendocrine tumors. Experimental Design: Thirty-six patients with advanced stages of …

Purpose: Unequivocal pathologic markers for the prognosis of pancreatic endocrine tumors
are often lacking. Suggestions for prognostic guidance include the WHO classification. …

Neuroendocrine tumors (NETs) can be small and situated almost anywhere throughout the
body. Our objective was to investigate whether whole-body (WB) positron emission …

We have evaluated survival and tumor-related symptoms in the presence of mesenteric lymph
node and liver metastases in relation to surgical procedures in 314 patients (148 women, …

BACKGROUND Patients with neuroendocrine gastrointestinal tumors usually present with
inoperable metastatic disease and severe hormonal symptoms. Specific chemotherapy, …